Ki-4.dgA

N/A

Report date: 2023/11/17 09:30:20
NME

Base Information

Drug NameKi-4.dgA
Drug Alias NameKi-4.dgA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 8 inhibitors
TargetsTumor necrosis factor receptor superfamily member 8
Therapy Area/IndicationsHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical CenterUniversity Of Cologne
Active IndicationsN/A
Inactive IndicationsHodgkin Disease

Other Information

ATC CodeN/A
Related LinksN/A